{"filing":{"accession_number":"0001753926-26-001463","cik":"0001819994","ticker":"RKLB","company_name":"Rocket Lab Corp","form":"8-K","filing_date":"2026-08-13","report_date":"2026-08-13","primary_document":"g085846_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1819994/000175392626001463/g085846_8k.htm"},"events":[{"id":27479,"run_id":25050,"accession_number":"0001753926-26-001463","anchor_item_number":"7.01","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.75,"summary":"The filing discloses Rocket Lab's entry into an equity distribution agreement (ATM program) with an aggregate offering price of $1,944,369,826 in common stock. While the company intends to use proceeds to fund the Iridium acquisition and reduce debt, the core disclosure is the establishment of a new equity issuance facility that permits substantial dilution to existing shareholders. The press release explicitly states this is a \"replacement\" ATM program carrying forward unsold amounts, and the company \"may offer and sell\" shares at market prices, making this a dilutive equity issuance material to investors assessing capital structure and ownership dilution.","company_name":"Rocket Lab Corp","ticker":"RKLB","filing_date":"2026-08-13","form":"8-K","submitted_at":null,"items":[{"id":29044,"accession_number":"0001753926-26-001463","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.75,"reasoning":"The filing discloses Rocket Lab's entry into an equity distribution agreement (ATM program) with an aggregate offering price of $1,944,369,826 in common stock. While the company intends to use proceeds to fund the Iridium acquisition and reduce debt, the core disclosure is the establishment of a new equity issuance facility that permits substantial dilution to existing shareholders. The press release explicitly states this is a \"replacement\" ATM program carrying forward unsold amounts, and the company \"may offer and sell\" shares at market prices, making this a dilutive equity issuance material to investors assessing capital structure and ownership dilution.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-13T11:11:54.189793+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":29044,"accession_number":"0001753926-26-001463","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.75,"reasoning":"The filing discloses Rocket Lab's entry into an equity distribution agreement (ATM program) with an aggregate offering price of $1,944,369,826 in common stock. While the company intends to use proceeds to fund the Iridium acquisition and reduce debt, the core disclosure is the establishment of a new equity issuance facility that permits substantial dilution to existing shareholders. The press release explicitly states this is a \"replacement\" ATM program carrying forward unsold amounts, and the company \"may offer and sell\" shares at market prices, making this a dilutive equity issuance material to investors assessing capital structure and ownership dilution.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-13T11:11:54.189793+00:00","company_name":"Rocket Lab Corp","ticker":"RKLB","filing_date":"2026-08-13"}]}